Advances in clinical applications of T-SPOT. TB for interferon-gamma release assay in the immunodiagnosis of tuberculosis / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
;
(6): 506-510, 2009.
Artigo
em Chinês
| WPRIM
| ID: wpr-301663
ABSTRACT
T-SPOT. TB is an interferon-gamma release assay to detect T-cell response to early secreting antigen target 6 and culture filtrate protein 10 peptides by enzyme-linked immunospot assay for tuberculosis diagnosis. It is highly sensitive and specific, and will not be affected by the subject's immune status and Bacillus Calmette-Guerin vaccination. This assay has been licensed for in-vitro diagnosis in Europe and the United States. Its potential roles in distinguishing active tuberculosis from latent tuberculosis infection and predicting active tuberculosis among individuals with latent tuberculosis have been increasingly studies. This article reviews the advances in the clinical application of T-SPOT. TB.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Tuberculose
/
Linfócitos T
/
Interferon gama
/
Diagnóstico
/
Testes de Liberação de Interferon-gama
/
Mycobacterium tuberculosis
Tipo de estudo:
Estudo diagnóstico
Limite:
Humanos
Idioma:
Chinês
Revista:
Acta Academiae Medicinae Sinicae
Ano de publicação:
2009
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS